Masaaki Furuta
Directeur/Membre du Conseil chez MEDIBIC GROUP
Provenance du réseau au premier degré de Masaaki Furuta
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Private Company | Miscellaneous Commercial Services | 14 | |
MediBIC KK
 MediBIC KK Miscellaneous Commercial ServicesCommercial Services Part of MediBIC Group, MediBIC KK develops genomic medicines. The company is based in Tokyo, Japan. The Japanese company was founded by Yasuhiro Hashimoto.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
MediBIC Pharma
4
| Subsidiary | 4 | |
Animal Stemcell KK
 Animal Stemcell KK BiotechnologyHealth Technology Part of MediBIC Group, Animal Stemcell KK engages in research and development, and production of animal stem cells and regenerative medicine. The company is based in Koganei, Japan. Animal Stemcell KK was acquired by MediBIC Group from Resort & Medical Co., Ltd. on October 08, 2013 for $3.02 million.
2
| Subsidiary | Biotechnology | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Masaaki Furuta via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Site Quality Co., Ltd.
 Site Quality Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Site Quality Co., Ltd. provides consulting services to medical institutions. It offers informed consent acquisition assistance, patient schedule administration, hospital data collection management, time monitoring, case report form preparation support, document creation assistance, and clinical research coordination. The company was founded in November 2003 and is headquartered in Hachioji, Japan. | Miscellaneous Commercial Services | President Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Osaka University | College/University | Doctorate Degree | |
EVOLUTION JAPAN Co., Ltd.
 EVOLUTION JAPAN Co., Ltd. Investment Banks/BrokersFinance EVOLUTION JAPAN Co., Ltd. engages in the business services industry with focus on commodity trading investments. It also operates in purchase and sale listed products; trading consignment business; collection, analysis, and provision of domestic, foreign, economy, and product related information; handling of precious metals and gold coins; and financial instruments brokerage. The company was founded in 1971 and is headquartered in Tokyo, Japan. | Investment Banks/Brokers | Chairman | |
| Frontier Consulting Japan KK | Chief Executive Officer | ||
| Waseda University | College/University | Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
Baring Securities Ltd.
 Baring Securities Ltd. Investment Banks/BrokersFinance Part of ING Groep NV, Baring Securities Ltd. is a Chinese company that provides securities brokerage services. The company is based in Hong Kong, Hong Kong. | Investment Banks/Brokers | Director/Board Member | |
| JAPAN ASSET MARKETING CO., LTD. | Real Estate Development | Director/Board Member | |
| Generation Group KK | Director/Board Member | ||
| BIO-Business Solutions | Director/Board Member | ||
| REVOLUTION CO., LTD. | Homebuilding | President | |
| QC Asset, Inc. | Director/Board Member | ||
| Seikei University | College/University | Graduate Degree | |
Ambicion KK
 Ambicion KK Miscellaneous Commercial ServicesCommercial Services Ambicion KK is a company based in Tokyo, Japan that focuses on developing novel cancer immunotherapies and allergy treatments. The Japanese company specializes in creating drugs that target NKT cells and promoting cancer immunotherapy that targets NKT cells, which is not covered by insurance. The company was founded in 2015, and the CEO is Kenji Suzuki. | Miscellaneous Commercial Services | Director/Board Member | |
| London School of Economics & Political Science | College/University | Undergraduate Degree | |
| University of Tokyo | College/University | Graduate Degree | |
| School of Engineering, Tohoku University | College/University | Doctorate Degree | |
| Showa University | College/University | Undergraduate Degree | |
| Atlas KK | Director/Board Member | ||
ECI, Inc.
 ECI, Inc. BiotechnologyHealth Technology ECI, Inc. engages in the business of innovative drug discovery and its related services. It operates through the following segments: Drug Discovery Business, Drug Discovery Tool Supply and Health Food. The Drug Discovery Business segment engages in the research and development of drug discovery seeds and core technology. The Drug Discovery Tool Supply segment develops and sells laboratory equipment. The Health Food segment sells health food ingredients and agricultural supplements in bulk. The company was founded by Shiro Kanegasaki in June 1999 and is headquartered in Tachikawa, Japan. | Biotechnology | President | |
| GlaxoWellcome /Pharmocology Unit/ | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Corporate Officer/Principal | |
Asia Private Equity Capital KK
 Asia Private Equity Capital KK Investment ManagersFinance Asia Private Equity Capital KK (APEC), is the venture capital subsidiary of West Wood Capital KK in Japan. Formerly known as MediBIC Alliance, established in 2004, APEC is headquartered in Tokyo with an office in Shanghai. The firm is majority-owned by a group of shareholders which includes management, with MediBIC holding a significant minority interest. In addition to managing a portfolio of direct participations in healthcare companies, APEC is involved in investment banking and IPO support activities for biotechnology companies in Japan and in Asia. The firm also sub-advises specialist investment funds for pharmaceutical companies and Japanese institutions including pension funds. APEC cooperates closely with pharmaceutical giant Daiichi Sankyo (TSE: 4568) and leverages an extensive global network of contacts in the pharmaceutical sector. | Investment Managers | President | |
Strand Life Sciences Pvt Ltd.
 Strand Life Sciences Pvt Ltd. Packaged SoftwareTechnology Services Strand Life Sciences Pvt Ltd. develops software for drug research. It offers developing and marketing of various diagnostics tests for cancer and hereditary diseases. The firm also offers liquid biopsy test, somatic test, hereditary cancer test and inherited diseases test. The company was founded by Vijay Chandru, Ramesh Hariharan, Srinivasan Seshadri, Vinay Vishwanathan and Swaminathan Manohar in 2000 and is headquartered in Bangalore, India. | Packaged Software | Director/Board Member | |
Taqtik Health, Inc.
 Taqtik Health, Inc. Internet Software/ServicesTechnology Services Taqtik Health, Inc. provides medical care services. Its services include consulting, case management, critical illness insurance, second opinion, records retrieval and travel and planning. The company was founded by Yasuhiro Hashimoto and Rachel Rowling in December 2015 and is headquartered in Sunnyvale, CA. | Internet Software/Services | Founder | |
| Riavvio, Inc. | Director/Board Member | ||
| PATH CORPORATION | Internet Retail | Founder | |
| METAPLANET INC. | Hotels/Resorts/Cruise lines | Director/Board Member | |
Dimension Pockets KK
 Dimension Pockets KK Hotels/Resorts/Cruise linesConsumer Services Dimension Pockets KK engages in development, management, construction, and sales of hotels, lodging house, pension house, and boarding houses. The company was founded on September 20, 2013 and is headquartered in Kunigami, Japan. | Hotels/Resorts/Cruise lines | President | |
| FULLCAST HOLDINGS CO., LTD. | Personnel Services | Director/Board Member | |
| Hamamatsu University | College/University | Undergraduate Degree | |
| EISAI CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| IP Alliance KK | President |
Statistiques
Internationale
| Japon | 27 |
| Etats-Unis | 7 |
| Royaume-Uni | 4 |
| Vietnam | 2 |
| Hong Kong | 2 |
Sectorielle
| Consumer Services | 14 |
| Commercial Services | 6 |
| Health Technology | 6 |
| Finance | 5 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 49 |
| President | 21 |
| Corporate Officer/Principal | 7 |
| Undergraduate Degree | 6 |
| Founder | 4 |
Relations les plus connectées
| Insiders | |
|---|---|
| Yasuhiro Hashimoto | 12 |
| John Fou | 8 |
| Kenji Hikita | 8 |
| Shiro Kaizuka | 6 |
| Akiyoshi Uchiyama | 6 |
| Takeshi Kanda | 6 |
| Hajime Kuboshima | 6 |
| Minoru Ono | 5 |
| Koji Kitami | 5 |
| Yutaka Kijima | 4 |
| Shizuo Koyama | 3 |
| Hiroki Nakae | 3 |
| Motoki Handa | 1 |
| Hiroshi Endo | 1 |
| Yasuo Suzuki | 1 |
- Bourse
- Insiders
- Masaaki Furuta
- Connexions Sociétés